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Antimicrobial Susceptibil ity Patterns in Urinary Tract Infections in
Dogs (2010–2013)
C. Wong, S.E. Epstein, and J.L. Westropp
Background: Urinary tract infections (UTIs) are common in dogs. The responsible bacterial populations have evolved
with increasing resistance to many antimicrobials.
Objective: To characterize the antimicrobial susceptibility patterns of canine urinary tract isolates over a 51-month
period.
Animals: One thousand six hundred and thirty-six bacterial isolates from 1,028 dogs.
Methods: Aerobic bacterial isolate growth and susceptibility data from urine cultures of dogs were identified, retrospec-
tively. Medical records were reviewed to obtain signalment, comorbidities, and antimicrobial use in the previous 30 days. The
UTIs were further categorized as uncomplicated, complicated, or pyelonephritis.
Results: Common bacterial isolates identified were Escherichia coli (52.5%), Staphylococcus spp. (13.6%), and Enterococ-
cus spp. (13.3%). In vitro susceptibility among all isolates varied for commonly prescribed antimicrobials (amoxicillin [59%],
amoxicillin/clavulanic acid [76%], cephalexin [66%], enrofloxacin [74%] and trimethoprim-sulfamethoxazole [86%]). For all
antimicrobials tested (except aminoglycosides), in vitro susceptibility was higher in uncomplicated versus complicated infec-
tions (P < .05). Uncomplicated infection isolate susceptibility rates remained ≤90% for PO administered antimicrobials.
Administration of amoxicillin, doxycycline, and enrofloxacin, but not amoxicillin/clavulanic acid in the previous 30 days was
associated with resistance to that antimicrobial. Multidrug resistant isolates of E. coli and Staphylococcus spp. were more
common in dogs with complicated than uncomplicated UTIs (36% versus 21%, P < .0001).
Conclusions and Clinical Importance: In vitro susceptibility was highly variable and no PO administered antimicrobial had
>90% efficacy among isolates tested. Multidrug resistance was frequent among isolates tested suggesting that routine culture
and susceptibility testing is indicated. Previously prescribed antimicrobials may affect empirical choices made pending suscep-
tibility testing.
Key words: Antimicrobial resistance; Bacterial resistance; Culture and susceptibility; Pyelonephritis; Uropathogens.
Bacterial urinary tract infections (UTIs) occur inapproximately 14% of dogs in their lifetime with
variable age of onset.1 Furthermore, in 1 study of 237
euthanized dogs, the incidence of UTIs was 26.6% in
females and 6.2% in males.2 Urinary tract infections
can be classified as simple uncomplicated, which is a
sporadic bacterial infection in an otherwise healthy indi-
vidual, or complicated, which is defined as a UTI that
occurs in the presence of an anatomic or functional
abnormality or a comorbidity that may predispose the
patient to persistent infection, recurrent infection or
treatment failure. Pyelonephritis is defined as an infec-
tion of the renal parenchyma.
Collection of urine by cystocentesis followed by com-
plete urinalysis and quantitative aerobic bacterial cul-
ture are recommended to confirm the presence of
bacterial UTI in dogs with signs of lower urinary tract
disease.3 However, empirical antimicrobial treatment
often is started for a presumptive diagnosis of UTI
based on clinical signs of lower urinary tract disease
(eg pollakiuria, stranguria, hematuria, or a combination
of these signs) with or without results of urine culture.
Repeated treatment of animals with recurrent lower uri-
nary tract signs without culture and susceptibility test
results may lead to incorrect antimicrobial choices,
unnecessary adverse effects of drug treatment, and pos-
sible selection of resistant bacterial populations.
Widespread antimicrobial resistance is an emerging
problem in small animal medicine4 and in human
beings.5 Empirical antimicrobial administration is not
without concerns because this practice may select for
multidrug resistant (MDR) organisms, disturb normal
flora and encourage colonization or infection.6 Histori-
cal use of antimicrobials has been shown to encourage
development of bacterial resistance in human beings
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with UTIs, not only to the antimicrobial in use, but
possibly to more than 1 class of antimicrobials, high-
lighting the importance of the correct selection of an
antimicrobial to treat a patient with a UTI.7–10
Although guidelines for treating UTIs have been pub-
lished for dogs and human beings,3,11,12 regional vari-
ability exists among isolates as well as susceptibility to
various antimicrobials.10,13 The population of affected
individuals can vary, with some hospitals treating more
patients with uncomplicated UTIs, whereas others may
see primarily patients with complicated UTIs. In addi-
tion, treatment for uncomplicated versus complicated
UTI may be different. For example, pyelonephritis,
which is categorized as a complicated UTI, initially
may be treated with parenterally rather than PO admin-
istered antimicrobials in some cases.14 In addition to
considering published guidelines for treating UTIs, cur-
rent local data and recent antimicrobial surveillance
play important roles in antimicrobial use as bacterial
populations evolve.
The main objectives of this study were (1) to identify
common urinary isolates involved in uncomplicated
UTI, complicated UTI and pyelonephritis, as well as
their associated susceptibility patterns at our tertiary
care facility, (2) to evaluate potential changes in suscep-
tibility patterns over time, and (3) to determine whether
historical antimicrobial use was associated with future
antimicrobial resistance in dogs with UTIs.
Materials and Methods
Data Collection
All urine samples obtained from dogs by cystocentesis that had
positive quantitative aerobic urine culture results and subsequent
antimicrobial susceptibility testing at the William R. Pritchard
Veterinary Medical Teaching Hospital between January 1, 2010
and September 10, 2013 were identified from an electronic data-
base. The William R. Pritchard Veterinary Medical Teaching Hos-
pital is a tertiary facility receiving cases from a large area of
northern California. We included antimicrobial susceptibility test-
ing on samples with bacterial counts ≥100 colony forming units
(CFU)/mL, because this is the minimal detection limit by the tech-
nique used for urine cultures in our hospital’s laboratory. To
provide a description of the population being studied, a colony
count was performed on 10% of isolates that had positive growth.
The corresponding medical records from these patients were
reviewed and the signalment including age (calculated in years
based on urine submission time), breed, and sex were recorded.
An enteric designation was given if the isolate was from the family
Enterobacteriaceae.
Urinary tract infections were further categorized from analysis
of the available medical record as uncomplicated, complicated or
pyelonephritis as previously described.3 For dogs with complicated
UTI, comorbidities were identified by the clinician’s assessment at
time of diagnosis combined with the client or referral history.
Comorbidities included diabetes mellitus, kidney disease (both
chronic kidney disease [CKD], and acute kidney injury), hyperad-
renocorticism, pyoderma, immune suppression (corticosteroid or
other immunosuppressive agent, chemotherapy administration, or
some combination of these), urolithiasis (upper or lower urinary
tract), anatomical abnormalities (eg recessed vulva, ectopic ureters,
urethral stricture) and urinary incontinence (including dogs with
thoracolumbar myelopathy and urethral sphincter mechanism
incompetency). Pyelonephritis was presumptively diagnosed based
on the final clinical diagnosis of the attending clinician which was
made based on clinical signs, clinicopathologic data and ultra-
sound examination results as available. Recurrent infections were
identified as ≥3 episodes of UTI documented by urine culture
within a 1-year time period, which categorizes the infection as a
complicated UTI. Historical antimicrobial use was identified by
previous prescription dispensation from pharmacy records or by
client or referral veterinarian history. If the antimicrobial was
administered to the dog within 30 days of the urine culture, the
antimicrobial used was recorded.
Isolates were considered susceptible if a susceptible classification
was assigned and resistant if an intermediate or resistant classifica-
tion was assigned according to the Clinical and Laboratory Stan-
dards Institutes recommendations for serum breakpoints.15 If not
available for dogs, human breakpoints were utilized. MDR organ-
isms were identified based on definitions proposed by a collabora-
tive effort between the Centers for Disease Control and Prevention
and the European Centre for Disease Prevention and Control for
enteric organisms and Staphylococcus spp.16 Bacteria were consid-
ered MDR if found to be resistant to 1 agent in ≥3 separate anti-
microbial categories in which the wild type bacteria would
normally be susceptible.
Statistical Analysis
Categorical data between groups were evaluated for a difference
in proportion with chi square or Fisher’s exact testing where
appropriate with commercially available software.a Susceptibility
patterns over years were compared using chi-squared test for
trends. For all comparisons, a value of P < .05 was considered
significant.
Results
From January 1, 2010 through September 30, 2013
1,636 aerobic bacterial isolates were identified from 1,028
dogs. A total of 54 (5.2%) of the dogs were <1 year of
age, 313 (30.4%) were between 1 and 7 years, and 661
(64.3%) were >7 years old. In 1 patient, the age was not
documented. Seven-hundred and sixty (74%) were
females, of which 684/1028 (66.5%) were spayed females
and 76/1028 (7.4%) were intact females. Two-hundred
and sixty-eight (26%) of the isolates obtained were from
males with 216/1028 (21.0%) being castrated males and
52/1028 (5.1%) intact males. The breeds most commonly
identified were Labrador Retrievers 148 (14.4%), Ger-
man Shepherds 44 (4.3%), Golden Retrievers 44 (4.3%),
and Dachshunds 41 (4.0%).
Of the 164 randomly selected isolates for CFU analy-
sis all were >100 CFU/mL and 143 were >1000 CFU/
mL (87.2%). Of the isolates with <1000 CFU/mL: 3
(1.8%) were from dogs on antimicrobials for treatment
of complicated UTIs, 3 (1.8%) were from dogs with
concurrent lower urinary tract signs and pyuria on uri-
nalysis, 2 (1.2%) were from dogs with uncontrolled dia-
betes mellitus, and 1 each (0.6%) were from a dog
receiving immunosuppressive drugs, a dog with chronic
perivulvar dermatitis being treated with antimicrobials,
and a dog with no clinical signs of lower urinary tract
disease.
Of the 1,028 incidents of infection, we classified 363
(35.3%) as uncomplicated and 665/1028 (64.7%) as
complicated. Of the complicated UTIs, 51/665 (7.7%)
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of dogs had pyelonephritis. Five-hundred and thirty-
two of 665 dogs with complicated UTI had a defined
comorbidity (Table 1). The most common comorbidities
were immune suppression (185 [34.7%]), kidney disease
(162 [30.4%]), and anatomic abnormality (135 [25.3%]).
Of those with anatomic abnormalities, the majority (71/
135 [52.5%]) had recurrent UTIs. The predominant
anatomical abnormality observed in recurrent UTIs was
recessed vulva 46/71 (64.7%), followed by ectopic ureter
6/71 (8.4%) with 1 patient having both. In 70/665
(10.5%) complicated UTI cases, an underlying comor-
bidity was not documented for the patient but the dogs
were classified as having complicated UTI based on
recurrent infections (Table 1). Two hundred and sev-
enty-nine (27.1%) dogs had recurrent or a persistent
infections.
Most infections, (793/1028 [77.1%]), were monomi-
crobial whereas (235/1028 [22.9%]) were polymicrobial.
The bacterial species isolated are reported in Table 2.
Most isolates were gram negative 1128 (68.9%), and of
these (1065/1128 [94.4%]) were enterics. In pyelonephri-
tis, the most common bacterial isolates were Escherichia
coli (50 [58.1%]), Enterococcus spp. (8 [9.3%]), Staphy-
lococcus spp. (6 [7.0%]), Proteus mirabilis (6 [7.0%]),
and Enterobacter spp. (6 [7.0%]). Of the subgroup of
complicated UTIs that had recurrent infections, regard-
less of underlying comorbidity, the most common bacte-
rial isolates were E. coli (273 [51.7%]), Enterococcus
spp. (90 [17.0%]), Staphylococcus spp. (65 [12.3%]),
Klebsiella spp. (27 [5.1%]), and Pseudomonas aeruginosa
(16 [3.0%]).
Isolates from dogs with uncomplicated UTI were
more likely to be gram negative (P = .04) and an enteric
organism (P = .006) compared with isolates obtained
from dogs with complicated UTI. Among the enteric
organisms, the proportion of E. coli was higher in
uncomplicated infections when compared with isolates
from dogs with complicated UTI (P = .03; Table 2).
One-hundred and fifty-three (50.8%) of E. coli UTIs in
uncomplicated cases were nonhemolytic compared with
312 (61.5%) in complicated infections (P = .003). The
proportion of Staphylococcus spp., Proteus spp., Klebsiella
spp., and Enterobacter spp. were not significantly different
Table 1. Distribution of comorbidities among dogs
with complicated urinary tract infections.
% (n) of
Comorbidities
Comorbidities (532)
Immune suppression 34.7 (185)
Renal disease 30.4 (162)
Hyperadrenocorticism 8.2 (44)
Diabetes mellitus 8.0 (43)
Urolithiasis 8.0 (43)
Pyoderma 4.8 (26)
Neoplasia 4.7 (25)
Incontinence 1.8 (10)
Anatomic abnormalities 25.3 (135)
Recessed vulva 17.4 (93)
Othera 3.3 (18)
Ectopic ureter(s) 2.2 (12)
Urethrostomy 1.1 (6)
Stricture (ureteral, urethral, or vaginal) 1.1 (6)
Total number of comorbidities exceeds number of dogs as some
dogs had multiple comorbidities listed.
aHymenal remnant 0.37 (2), abnormal bladder wall 0.75 (4),
vestibulovaginal stenosis 0.18 (1) urethral duplication/diverticulum
0.56 (3), urethral prolapse 0.37 (2), renal dysplasia 0.18 (1), peri-
vulvar hyperplasia/mass 0.75 (4), paraphimosis 0.18 (1).
Table 2. Bacterial isolates identified in canine urinary tract infections (UTI) classified as uncomplicated UTI, com-
plicated UTI and pyelonephritis. P value based on Fisher’s exact test for difference in proportion of isolates in
uncomplicated and complicated UTIs.
All Organisms
% (n)
Pyelonephritis
% (n)
Uncomplicated
% (n)
Complicated
% (n)
P
Value
Total (1636) (86) (522) (1028)
Gram positive 31.0 (508) 18.6 (16) 28.3 (148) 33.5 (344) .04
Staphylococcus spp. 13.7 (224) 7.0 (6) 12.3 (64) 15.0 (154) .75
Enterococcus spp. 13.4 (220) 9.3 (8) 12.3 (64) 14.4 (148) .96
Other Gram positivea 3.9 (64) 2.3 (2) 3.8 (20) 4.1 (42) .76
Gram negative 68.9 (1128) 81.4 (70) 71.6 (374) 66.5 (684) .04
Enterics 65.1 (1065) 76.7 (66) 69.5 (363) 61.9 (636) .006
Escherichia coli 52.4 (858) 58.1 (50) 57.7 (301) 49.3 (507) .03
Non-hemolytic 29.9 (489) 27.9 (24) 29.3 (153) 30.3 (312) .14
Hemolytic 22.7 (371) 30.2 (26) 28.4 (148) 19.0 (195) .003
Proteus mirabilis 5.4 (89) 7.0 (6) 5.9 (31) 5.1 (52) .20
Enterobacter spp. 1.8 (29) 7.0 (6) 1.3 (7) 1.6 (16) .66
Klebsiella spp. 3.7 (61) 3.5 (3) 2.9 (15) 4.2 (43) .09
Other gram negative entericsb 1.7 (28) 1.1 (1) 1.7 (9) 1.8 (18) 1.0
Non-enterics 3.9 (63) 4.7 (4) 2.1 (11) 4.7 (48) .005
Pseudomonas spp. 2.0 (33) 2.3 (2) 1.5 (8) 3.6 (37) .01
Nonenterics: Acinetobacter baumannii, Alcaligenes faecalis, Pasteurella spp., Providencia rettgeri, Stenotrophomonas maltophilia.
aAerococcus viridans, Corynebacterium spp., Lactobacillus spp., Lactococcus spp., Micrococcus spp., Streptococcus spp.
bCitrobacter spp., Salmonella enteritidis, Serratia marcescens, Yersinia enterocolitica.
Antimicrobials in Canine UTIs 1047
in dogs with uncomplicated and complicated infections.
Isolates from dogs diagnosed with pyelonephritis were
more likely to be gram negative (P = .003) and be an
enteric species (P = .007) than isolates from dogs with
other types of complicated UTI. The proportions of all
other bacteria were not significantly different between these
2 groups.
Isolates obtained from dogs with complicated UTIs
were significantly more resistant to amoxicillin/clavulanic
acid, ampicillin, chloramphenicol, doxycycline, enroflox-
acin, ticarcillin/clavulanic acid and trimethoprim-sulfa-
methoxazole (TMS) when compared with isolates from
dogs with uncomplicated UTIs (Table 3). However, iso-
lates obtained from dogs with documented pyelonephritis
only were more resistant to amoxicillin/clavulanic acid
and TMS when compared with isolates from dogs with
uncomplicated UTI (Table 3). On a longitudinal basis,
an increase in resistance rates over time among all iso-
lates was observed with amikacin (P = .027), gentamicin
(P = .021) and ticarcillin/clavulanic acid (P = .014), but
not for any other antimicrobial tested.
Isolates identified from dogs that had received amoxi-
cillin, doxycycline, or enrofloxacin 30 days before cul-
ture results were obtained showed significantly higher
resistance rates to those antimicrobials (P = .003,
P < .0001, P < .0001, respectively) when compared with
dogs that did not receive those antimicrobials before
urine cultures were obtained. There was no difference in
resistance rates of isolates identified from dogs that
were treated with cephalexin or amoxicillin/clavulanic
acid in the previous 30 days than from isolates from
dogs not on those specific antimicrobials, respectively
(Table 4).
Among Staphylococcus spp. and enteric spp. isolated,
401/1285 (31.2%) were MDR with 79/224 (79%) Staph-
ylococcus spp. and 322/1061 (30.3%) enteric species
being categorized MDR. The proportion of MDR
isolates from dogs with complicated UTI was signifi-
cantly higher 294/790 (36%) compared with isolates
from dogs with uncomplicated infections 91/427 (21%;
P < .0001).
Discussion
In this study, we documented a stable level of resis-
tance against commonly prescribed antimicrobials over
the study period, but a significantly higher frequency of
bacterial resistance from isolates obtained from dogs
with complicated UTI compared with those with
uncomplicated UTI. Furthermore, many of these dogs
had received antimicrobials previously that may have
contributed to the overall increase in bacterial resistance
in dogs with complicated UTI. We also documented
multidrug resistance in many dogs with UTIs. Recur-
rent infections often were associated with various com-
orbidities.
Dogs included in this study more commonly had
complicated UTI. The higher frequency of complicated
infections likely is attributable to our hospital being a
tertiary care facility, receiving referrals for recurrent
UTI, as well as dogs undergoing treatment for many of T
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the comorbidities reported in this study. Different
results might have been obtained from a primary care
facility or in other geographical locations.
In this large group of dogs with UTIs, large variabil-
ity was observed in the susceptibility rates of bacterial
isolates, with none achieving >90% susceptibility to any
PO administered antimicrobial option. This patient
population is similar to that of other studies, with the
average age being >7 years old, as well as the docu-
mented higher frequency in female dogs.2,17–19 Similar
to other studies, no breed predispositions were found
for UTI and the breeds represented likely reflected
breed popularity during the study period.
Evaluating patients for comorbidities is particularly
important for cases of recurrent UTI.20 In our study,
the most common concurrent disease in dogs with com-
plicated UTI was immune suppression. This finding is
similar to a previous study that identified impaired
immunity as a disorder that may contribute to reinfec-
tions or persistent infections.20 These are not unex-
pected findings because it is estimated that 18–39% of
dogs on long-term corticosteroids treatment will
develop UTIs.21,22 In addition to immune suppression,
kidney disease was the second most common comorbid-
ity identified. These included cases of acute and CKDs,
as reported by the attending clinician, but pyelonephri-
tis was deemed unlikely based on the other clinical fea-
tures of the case. However, subclinical pyelonephritis
cases could have been inadvertently included in this
population because of the retrospective nature of the
study and difficulty in documenting pyelonephritis. In
human beings, patients with CKD are reported to have
impaired host immunity at all stages of CKD,23 thus it
is not surprising that dogs with CKD also may be sus-
ceptible to recurrent infections. Other comorbidities are
similar between dogs and humans presented with recur-
rent UTI.24
In a study of 100 dogs with recurrent UTI, anatomic
defects were the second most common disorder associ-
ated with infection,20 and it was the third most common
problem noted at our institution. The larger population
we evaluated or the referral nature of the institution
might have contributed to this slight difference. Evalu-
ating patients for anatomic abnormalities is essential,
because their correction can help prevent future UTIs.
In 1 study, episioplasty for correction of a recessed
vulva improved outcome in 13/16 dogs with respect to
UTI.25
A total of 8% of our dogs had diabetes mellitus doc-
umented as a comorbidity. Although diabetes mellitus
has been associated with UTI in the dog,26 it was not a
common comorbidity documented in this study.
Patients with diabetes mellitus are predisposed to infec-
tion because urinary and tissue glucose can impair neu-
trophil function and affect a wide variety of other
factors that might alter the immune system and micturi-
tion.27,28 Therefore, controlling diabetes may improve
the health of the urinary tract.
Escherichia coli comprised 80% of the gram-negative
enterics in our study, representing the most common
isolate in all categories of UTIs, which is consistent
with the findings of other studies.2,17–19 This observa-
tion likely is associated with the many mechanisms of
virulence that these bacteria possess as discussed in
other studies.13,18,29 Additional studies are indicated to
differentiate the origins of these isolates as gastrointesti-
nal commensals, environmental organisms or extraintes-
tinal uropathogenic E. coli. The second most common
organism identified was Staphylococcus spp. These
results are consistent with previous studies in which
Staphylococcus spp. were the second or third most com-
mon isolate reported in dogs.17,18
Approximately 30% of dogs in this study had recur-
rent UTI, which is higher than in previous studies, in
which recurrent or persistent UTI were reported to be
present in up to 4.5% of dogs with UTI.29 In a previous
study performed at this hospital, such infections were
identified in 0.3% of all hospital patients.29,30 This find-
ing likely reflects our hospital now being primarily a
tertiary care facility, to which patients with recurrent
infections are referred, and the nature of the disease for
which the dogs were presented required multiple urine
cultures. However, the frequency of recurrent UTI in
the general population is likely to be lower than that
observed in this study. Identifying the infections as
recurrent, relapsing or persistent was beyond the scope
of our study because many dogs were lost to follow-up
and subsequent re-evaluations were performed by the
primary care veterinarians. Therefore, the incidence of
recurrent UTI actually may have been higher in this
Table 4. Percent isolates susceptible to designated antimicrobial cultured from dogs that had received (column A)
or not received (column B) the antimicrobial within 30 days before obtaining the urine culture.
A B
P ValueAntimicrobial
% (n) of Isolates that were Susceptible
to the Designated Antimicrobial for Dogs being
Administered that Antimicrobial within 30 days
Before Culture
% (n) of Isolates that were Susceptible
to the Designated Antimicrobial from
Dogs that had not Received any Antimicrobials
within 30 days Before Culture
Amoxicillin/
clavulanic acid
73.8 (107) 76.9 (1118) .86
Cephalexin 72.1 (31) 66.0 (1034) .38
Amoxicillin 41.3 (26) 60.2 (903) .003
Doxycycline 40.0 (17) 72.6 (1125) <.0001
Enrofloxacin 28.4 (23) 77.2 (1103) <.0001
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population. The most common isolates obtained from
dogs with complicated UTIs in other studies (E. coli,
Enterococcus spp., Staphylococcus spp., and Klebsiella
spp.) are in agreement with these findings.20,30 There
was a higher prevalence of Pseudomonas spp. (3.0%) in
recurrent cases, which is similar to what was observed
in other studies,20,30 likely reflecting the intrinsic patho-
genicity of these bacteria.
In vitro resistance to commonly tested antimicrobials
was higher for isolates obtained from dogs with compli-
cated UTI, which is not unexpected because a number
of complicated infections may be recurrent and there-
fore more resistant because of previously used antimi-
crobial. Historic single or multiple antimicrobial usage
can lead to the development of resistance over time as
well as select for MDR bacteria.6,8,11 In addition, reso-
lution may be compromised by a comorbidity that pro-
motes colonization. However bacteria with a higher
level of intrinsic resistance were more likely to be found
in complicated UTIs, and a higher proportion of non-
hemolytic E. coli was found in dogs with complicated
UTI.
Even in uncomplicated UTIs, no PO administered
antimicrobial had a susceptibility rate >90%. This find-
ing is in contrast to recent findings in a study of 27
dogs with uncomplicated UTI and positive cultures that
found 100% susceptibility to both TMS and cepha-
lexin,31 but this study had fewer cases and in our study,
we documented bacteria intrinsically resistant to TMS
and cephalexin that were not present in the other study.
Some of these dogs actually may have had complicated
UTI, and underlying comorbidities may not have been
identified because they are not always investigated on
initial presentation. Our findings highlight the need for
quantitative aerobic bacterial urine culture and suscepti-
bility testing when UTI is suspected, even when it is the
first UTI for a patient. Antimicrobial treatment should
be based on these results whenever possible.
Over the study period, isolates were documented to
be significantly more resistant to amikacin, ticarcillin/
clavulanic acid, and gentamicin, but this was not
observed with more commonly used antibiotics. One
possible explanation could be that bacteria with intrin-
sic resistance to those antimicrobials were isolated
rather than an increase in acquired resistance during the
study period. If increasing antimicrobial resistance was
caused by an increase in acquired resistance by bacterial
pathogens, then cross resistance over variable classes of
antimicrobials was likely implicated, because these 3 an-
timicrobials were not commonly prescribed for dogs
with urinary tract problems. Development of resistance
to other classes of antimicrobials, other than those pre-
scribed, can occur with use of multiple antimicrobials
suggesting plasmid-mediated mechanisms of resis-
tance.8,13 For example, in E. coli (the largest repre-
sented isolate in this study) aminoglycoside resistance
often is plasmid mediated. Plasmids containing genes
for fluoroquinolone resistance commonly contain genes
for aminoglycoside resistance32,33. Fluoroquinolones fre-
quently are prescribed in this setting and may have
caused a change in resistance to aminoglycosides over
the study period. These findings warrant further investi-
gation.
The high incidence of MDR may be unique to our
patients in this tertiary facility, because they often are
presented for complicated or recurrent UTIs, or both
and may not reflect the general population, or the
organisms may represent an expanding population of
MDR bacteria in veterinary medicine. Severe underlying
illness, hospitalization for ≥3 days, and surgical inter-
vention have been reported to be common in dogs with
extraintestinal infections of MDR E. coli and Enterob-
acter.34 Prior antimicrobial treatment with beta-lactams,
fluoroquinolones and first generation cephalosporins
also may be a risk factor.34,35 In a study of MDR
E. coli UTI in cats, the number of antibiotic groups
used within a 3-month period was associated with
increased risk for infection.35 With the high incidence of
recurrent infections in this study, antimicrobial use
within the previous 30 days (as seen with amoxicillin,
doxycycline, and enrofloxacin) could have led to the
MDR isolates found in this study, further emphasizing
the need for culture and susceptibility testing before ini-
tiating treatment. This is especially important when
prior antimicrobial treatment has been administered.
One must be careful when comparing breakpoint
results among populations. Our results were based on
serum breakpoints, not urine breakpoints. Many anti-
microbials attain higher concentrations in the urine
compared with serum as long as renal function is nor-
mal because the majority of these drugs are eliminated
through the kidneys. Therefore, a higher rate of suscep-
tibility among isolates may be noted if traditional uri-
nary breakpoints are used (amoxicillin and amoxicillin-
clavulanic acid, which are higher than serum), whereas
not with other antimicrobials such as the fluoroquinol-
ones in which urine and serum breakpoints are the
same.15,36 This difference in established urinary break-
points provided for dogs have been limited to ampicil-
lin, enrofloxacin, difloxacin, marbofloxacin, and
orbifloxicin during the study period.15 After the end of
the study period, an additional canine specific urinary
tract breakpoint was developed for amoxicillin-clavulan-
ic acid.36 In uncomplicated UTIs, some investigators
consider it reasonable to use urinary breakpoints to
determine susceptibility, but for complicated UTIs and
pyelonephritis serum breakpoints are preferred.3 The
disadvantage of urinary breakpoints for uncomplicated
UTI cases is that if the uropathogen has invaded the
bladder wall, these results could lead to ineffective treat-
ment and the potential for persistent or recurrent UTIs.
The Antimicrobial Guidelines Working Group of the
International Society for Companion Animal Infectious
Diseases recommends using serum breakpoint interpre-
tive criteria for UTIs.3 These recommendations have
been applied at our institution’s microbiology labora-
tory throughout the study period.
This study has the limitations inherent to a retrospec-
tive study. We relied upon the attending clinician to
properly categorize the infections as pyelonephritis and
some infections may have been miscategorized. This
could have resulted in cases of pyelonephritis not being
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included in this subset of complicated UTI or cases
included inappropriately. We chose to provide data
from this group of complicated UTIs separately because
the diagnosis of other comorbidities associated with
complicated UTI (eg urolithiasis, neoplasia, recessed
vulva) are more easily confirmed using routine diagnos-
tic tests. We required that all infections be documented
at our institution and therefore may have underesti-
mated the true number of recurrent infections if subse-
quent urine cultures were performed by the primary
care veterinarian. In addition, quantitation of bacterial
counts was not evaluated, but our primary focus was to
evaluate potential changes in trends related to antimi-
crobial susceptibility over time. Our results may not
apply to the majority of simple UTIs, because our hos-
pital is a tertiary care facility that receives a larger num-
ber of dogs with complicated infections.
Finally, although clinically relevant bacteriuria is con-
sidered >1000 CFUs/mL for dogs that have not
received antimicrobials, we included urine samples
obtained by cystocentesis that had bacterial counts
>100 CFU/mL because of the varied histories and our
interest in identifying cases that possibly had received
antimicrobial treatment. The primary focus of our study
was to evaluate for the development of bacterial resis-
tance. Furthermore, random sampling of a subgroup of
isolates from this study confirmed that most dogs
(87%) fit the classical definition of a UTI (ie
>1000 CFU/mL). Of the isolates from dogs that did not
meet this criterion, all but 1 were either receiving anti-
microbial treatment or had a concurrent disease that
resulted in isosthenuria, likely lowering the colony
count. Interpreting both colony counts and clinical
signs are important considerations for the clinician in
deciding whether or not to prescribe antimicrobial treat-
ment. Recommendations for intention to treat however
were beyond the scope of our paper.
Conclusion
Many recurrent UTIs were considered complicated
and a concurrent comorbidity could be documented. In
vitro susceptibility was highly variable and no PO
administered antimicrobial had >90% efficacy among
all isolates tested. A stable level of resistance for com-
monly prescribed antimicrobials was observed over the
study period. Multidrug resistance was frequent in this
population. Previously, prescribed antimicrobials may
affect empirical choices pending susceptibility testing.
Routine culture and susceptibility testing is recom-
mended when UTI is suspected, especially when recur-
rent UTI is suspected and in those dogs that have
received previous antimicrobial treatment.
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